Dr Robert Smith completed Bachelors degrees in Applied Physics and Electronic Engineering at RMIT University in 2008 and has since completed a PhD and subsequent post-doctoral research at the Florey Institute of Neuroscience and Mental Health. His research focuses on the development of advanced processing and reconstruction methods for the analysis of diffusion MRI data, which enable robust inference of brain white matter connectivity and derivation of / inference on quantitative measures in the presence of complex white matter fibre configurations. These developments, in addition to other advanced data processing tools, are made freely available to the research community as part of the software package MRtrix3, for which extensive community support is provided via online forum and software teaching workshops. Dr Smith additionally provides support for the two 3T human MRI systems installed at the Melbourne Brain Centre in Heidelberg, which includes the recent Siemens Prisma scanner upgrade.
Reported by 9News, Clinical Director of The Florey Professor Graeme Jackson was interviewed about the technology developed at the Australian Epilepsy project.
26 June 2025
Donanemab, developed by Lilly, is the first disease-modifying treatment for early-stage Alzheimer’s disease to be approved for use in Australia. The National Imaging Facility supported its developme
16 June 2025
Dr Sicong Tu is excited about helping motor neurone disease (MND) patients gain a much better idea of their disease progression: “The focus of our network is on bridging the gap between leading Aust
28 May 2025
Our brains work a bit like highly advanced supercomputers, with bundles of white matter, known as ‘tracts,’ acting as superhighways that facilitate information flow and enable various brain functi
05 September 2024